31/01/17

Palm oil under fire as potential carcinogen

palm oil products made from sustainable means
Copyright: Panos

Speed read

  • Palm oil said to generate a carcinogenic contaminant when processed
  • Its major component, palmitic acid, boosts metastases or cancer spread
  • No human epidemiological study has yet been done on cancer risk from palm oil

Send to a friend

The details you provide on this page will not be used to send unsolicited email, and will not be sold to a 3rd party. See privacy policy.

[JAKARTA] An Indonesian food technologist admits that palm oil — which is widely used in the processed food industry — has a potentially carcinogenic contaminant, but says no epidemiological study has been carried out on its impact on human health.
 
Controversy has raged over the carcinogenic potential of palm oil since May 2016 when the European Food Safety Authority (EFSA) claimed in a statement that palm oil “generated more of a potentially carcinogenic contaminant than other vegetable oils when refined at temperatures above 200 degrees Celsius.”

“In risk assessments of such compounds, evidence from human epidemiological studies are not needed in order to conclude on the human health risk.”

Hellen Knutzen, EFSA

 

In January, Nature published the results of a study which showed that palmitic acid (major part of palm oil) boosts metastases (spread of cancer) through CD36 — a specific protein found in cancer cells that is responsible for taking up fatty acids.
 
The EFSA statement said palm oil generates glycidyl fatty acid ester (GE) when the refining process reaches temperatures above 200 degrees Celsius. Donald Siahaan, senior food technologist at the Indonesian Oil Palm Research Institute, says that while GE has been proven to be carcinogenic, it still does not warrant a ban on palm oil.
 
“Firstly, no international standard has been set for GE concentration in palm oil and the contaminant naturally exists in many foods including those processed from soybeans,” Siahaan tells SciDev.Net. Secondly, says Siahaan, research concerning GE has been limited to laboratories. “Food is complex. What happens in the laboratory does not always happen in our body because there are so many factors which influence chemical reactions.”
 
According to Siahaan, only a long-term epidemiological study, involving a large number of participants and done over at least 10 years, can establish the level of risk in consuming palm oil. Siahaan’s arguments echoed a defence of palm oil put up by Ferrero, the manufacturers of Nutella, the popular spread, following the EFSA statement. Ferrero uses up some 185,000 tonnes of palm oil annually.
 
However, Hellen Knutzen, chair of the Contaminants in the Food Chain panel of the EFSA that investigated palm oil, says there is enough evidence to conclude that glycidol is genotoxic and carcinogenic.
 
“In risk assessments of such compounds, evidence from human epidemiological studies are not needed in order to conclude on the human health risk,” Knutzen explains to SciDev.Net.
 
Knutzen says that assessors investigate the margin between the dose that causes cancer in experimental animals and the dose that humans are exposed to. If the margin is not sufficiently large, it is concluded that there is a potential human health concern.

While EFSA is not empowered to make regulations, the European Commission is contemplating steps that may include setting permissible levels of GE in food items. 
 
Siahaan says Indonesia’s agricultural ministry plans to conduct its own survey of GE concentrations in palm oil across the country. Indonesia, the world’s biggest palm oil producer, has a target to produce 40 million tonnes of palm oil annually by 2020. 
 
This piece was produced by SciDev.Net’s South-East Asia & Pacific desk.